Basit öğe kaydını göster

The CYP 2C19*2 and CYP2C19*17 polymorphisms play a vital role in platelet responsiveness to clopidogrel after percutaneous coronary intervention: a pharmacogenomic study

dc.contributor.authorSaydam, Faruk
dc.contributor.authorDeğirmenci, İrfan
dc.contributor.authorBirdane, A.
dc.contributor.authorOzdemir, M.
dc.contributor.authorUlus, T.
dc.contributor.authorÖzbayer, Cansu
dc.contributor.authorÇolak, E.
dc.contributor.authorAta, N.
dc.contributor.authorGüneş, H.V.
dc.date.accessioned2020-12-19T19:56:52Z
dc.date.available2020-12-19T19:56:52Z
dc.date.issued2015
dc.identifier.citationSaydam, F., Değirmenci, İ., Birdane, A., Özdemir, M., Ulus, T., Özbayer, C., Çolak, E., Ata, N., & Güneş, H. V. (2017). The CYP2C19*2 and CYP2C19*17 Polymorphisms play a Vital Role in Clopidogrel Responsiveness after Percutaneous Coronary Intervention: A Pharmacogenomics Study. Basic & clinical pharmacology & toxicology, 121(1), 29–36. https://doi.org/10.1111/bcpt.12763en_US
dc.identifier.issn0149-2918
dc.identifier.issn1879-114X
dc.identifier.urihttps://doi.org/10.1016/j.clinthera.2015.05.146
dc.identifier.urihttps://hdl.handle.net/11436/2790
dc.description12th Congress of the European-Association-for-Clinical-Pharmacology-and-Therapeutics -- JUN 27-30, 2015 -- Madrid, SPAINen_US
dc.descriptionOzbayer, Cansu/0000-0002-1120-1874; Colak, Ertugrul/0000-0003-3251-1043en_US
dc.descriptionWOS: 000384951200135en_US
dc.description.abstractBackground: Clopidogrel inhibits platelet activation and aggregation by blocking the P2Y12 receptor. Dual antiplatelet therapy with clopidogrel and aspirin is recommended treatment by current guidelines for patients undergoing percutaneous interventions.en_US
dc.description.sponsorshipEuropean Assoc Clin Pharmacol & Therapeuten_US
dc.language.isoengen_US
dc.publisherElsevieren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleThe CYP 2C19*2 and CYP2C19*17 polymorphisms play a vital role in platelet responsiveness to clopidogrel after percutaneous coronary intervention: a pharmacogenomic studyen_US
dc.typeconferenceObjecten_US
dc.contributor.departmentRTEÜ, Tıp Fakültesi, Temel Tıp Bilimleri Bölümüen_US
dc.contributor.institutionauthorSaydam, Faruk
dc.contributor.institutionauthorGüneş, H.V.
dc.identifier.doi10.1016/j.clinthera.2015.05.146
dc.identifier.volume37en_US
dc.identifier.issue8en_US
dc.identifier.startpageE48en_US
dc.identifier.endpageE48en_US
dc.ri.editoaen_US
dc.relation.journalClinical Therapeuticsen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail
Ad:
saydamm-201.pdf
Boyut:
47.26Kb
Biçim:
PDF
Açıklama:
Full Text / Tam Metin
Göster/Aç

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster